A detailed history of Momentum Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Momentum Advisors, LLC holds 4,246 shares of NVO stock, worth $360,910. This represents 0.59% of its overall portfolio holdings.

Number of Shares
4,246
Previous 4,307 1.42%
Holding current value
$360,910
Previous $429,000 33.8%
% of portfolio
0.59%
Previous 0.47%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $6,255 - $8,255
-61 Reduced 1.42%
4,246 $574,000
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $410,370 - $503,617
4,307 New
4,307 $429,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Momentum Advisors, LLC Portfolio

Follow Momentum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Momentum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Momentum Advisors, LLC with notifications on news.